BRPI0721969A2 - regime de dosagem de ibuprofeno de liberação imediata e de liberação sustentada - Google Patents

regime de dosagem de ibuprofeno de liberação imediata e de liberação sustentada

Info

Publication number
BRPI0721969A2
BRPI0721969A2 BRPI0721969A BRPI0721969A BRPI0721969A2 BR PI0721969 A2 BRPI0721969 A2 BR PI0721969A2 BR PI0721969 A BRPI0721969 A BR PI0721969A BR PI0721969 A BRPI0721969 A BR PI0721969A BR PI0721969 A2 BRPI0721969 A2 BR PI0721969A2
Authority
BR
Brazil
Prior art keywords
dosing regimen
release
sustained release
immediate release
immediate
Prior art date
Application number
BRPI0721969A
Other languages
English (en)
Inventor
Der-Yang Lee
Frank Bunick
James Schwing
Original Assignee
Mcneil Ppc Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mcneil Ppc Inc filed Critical Mcneil Ppc Inc
Publication of BRPI0721969A2 publication Critical patent/BRPI0721969A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/2873—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2893—Tablet coating processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
BRPI0721969A 2007-08-15 2007-08-15 regime de dosagem de ibuprofeno de liberação imediata e de liberação sustentada BRPI0721969A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/US2007/075990 WO2009023030A1 (en) 2007-08-15 2007-08-15 Immediate release and sustained release ibuprofen dosing regiment
US11/839,168 US8137694B2 (en) 2007-08-15 2007-08-15 Immediate release and sustained release ibuprofen dosing regimen

Publications (1)

Publication Number Publication Date
BRPI0721969A2 true BRPI0721969A2 (pt) 2015-09-29

Family

ID=59676846

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0721969A BRPI0721969A2 (pt) 2007-08-15 2007-08-15 regime de dosagem de ibuprofeno de liberação imediata e de liberação sustentada

Country Status (13)

Country Link
US (2) US8137694B2 (pt)
EP (2) EP2190418B1 (pt)
JP (1) JP5345620B2 (pt)
KR (1) KR101458774B1 (pt)
CN (1) CN101784262A (pt)
AU (4) AU2007357647A1 (pt)
BR (1) BRPI0721969A2 (pt)
CA (1) CA2696063C (pt)
ES (1) ES2438267T3 (pt)
HK (1) HK1144071A1 (pt)
MX (1) MX2010001789A (pt)
PL (1) PL2190418T3 (pt)
WO (1) WO2009023030A1 (pt)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2190418B1 (en) * 2007-08-15 2013-10-02 Mcneil-PPC, Inc Immediate release and sustained release ibuprofen dosing regimen
JP2012523377A (ja) * 2009-03-12 2012-10-04 カンバーランド ファーマスーティカルズ インコーポレイテッド 静脈内イブプロフェンの投与
US8735452B2 (en) * 2009-07-15 2014-05-27 Cumberland Pharmaceuticals Inc. Treating patients with intravenous ibuprofen
US8871810B2 (en) * 2009-07-15 2014-10-28 Cumberland Pharmaceuticals Inc. Treating critically ill patients with intravenous ibuprofen
US20110028556A1 (en) * 2009-07-31 2011-02-03 Cumberland Pharmaceuticals, Inc. Treating critically ill patients with intravenous ibuprofen
CN102160855B (zh) * 2011-03-30 2013-01-23 吴家安 右旋布洛芬缓释片及制备方法
CN102813638A (zh) * 2011-06-07 2012-12-12 贵阳医学院 一种右旋酮洛芬氨丁三醇双层缓释片的制备方法
JP2015503583A (ja) * 2012-01-04 2015-02-02 ウェルズリー ファーマスーティカルズ、エルエルシー 排尿頻度を減少させるための延長放出製剤およびその使用の方法
JP2015507003A (ja) * 2012-02-20 2015-03-05 ルピン・リミテッドＬｕｐｉｎ Ｌｉｍｉｔｅｄ ドロネダロンの二層錠剤
US9072661B2 (en) 2012-03-16 2015-07-07 Cumberland Pharmaceuticals Inc. Injectable ibuprofen formulation
US9072710B2 (en) 2012-03-16 2015-07-07 Cumberland Pharmaceuticals Inc. Injectable ibuprofen formulation
US20140037725A1 (en) * 2012-08-01 2014-02-06 Cadila Healthcare Limited Bilayer pharmaceutical compositions of naproxen
US11229600B2 (en) * 2014-09-24 2022-01-25 Vital Beverages Global Inc. Compositions and methods for selective GI tract delivery
WO2017062027A1 (en) * 2015-10-09 2017-04-13 Bayer Healthcare Llc Modified release formulation of naproxen sodium
CA3013123A1 (en) 2016-02-04 2017-08-10 Cinrx Pharma, Llc Deuterated domperidone compositions and methods for therapy of disorders
ES2958616T3 (es) 2017-03-08 2024-02-12 Cinrx Pharma Llc Formulaciones farmacéuticas de floroglucinol y trimetilfloroglucinol
US11364226B2 (en) 2017-06-30 2022-06-21 Cinrx Pharma, Llc Deuterated domperidone compositions, methods, and preparation
TR201721036A2 (tr) * 2017-12-21 2019-07-22 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Flurbi̇profeni̇n modi̇fi̇ye salimli formülasyonlari
CN110037994B (zh) * 2019-05-24 2022-04-12 中国药科大学 一种布洛芬速释缓释双层片及其制备方法
CN113842371A (zh) * 2021-10-11 2021-12-28 江苏集萃新型药物制剂技术研究所有限公司 一种双相释药组合物、双相释药固体药剂及其制备方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1497044A (en) * 1974-03-07 1978-01-05 Prodotti Antibiotici Spa Salts of phenyl-alkanoic acids
US4873231A (en) 1986-04-08 1989-10-10 Smith Walton J Decreasing the toxicity of an ibuprofen salt
IT1200178B (it) * 1986-07-23 1989-01-05 Alfa Farmaceutici Spa Formulazioni galeniche a cessione programmata contenenti farmaci ad attivita' antiflogistica
CA2061520C (en) 1991-03-27 2003-04-22 Lawrence J. Daher Delivery system for enhanced onset and increased potency
IT1264855B1 (it) 1993-06-21 1996-10-17 Zambon Spa Composizioni farmaceutiche contenenti sali dell'acido s(+)-2-(4-isobutilfenil) propionico con amminoacidi basici
IT1264696B1 (it) * 1993-07-09 1996-10-04 Applied Pharma Res Forme farmaceutiche destinate alla somministrazione orale in grado di rilasciare sostanze attive a velocita' controllata e differenziata
US6183778B1 (en) * 1993-09-21 2001-02-06 Jagotec Ag Pharmaceutical tablet capable of liberating one or more drugs at different release rates
IT1276689B1 (it) 1995-06-09 1997-11-03 Applied Pharma Res Forma farmaceutica solida ad uso orale
IL128043A (en) * 1997-05-30 2004-08-31 Osmotica Corp Multi-layered osmotic device for controlled delivery of active agents
US6753009B2 (en) * 2002-03-13 2004-06-22 Mcneil-Ppc, Inc. Soft tablet containing high molecular weight polyethylene oxide
MXPA05010010A (es) 2003-03-21 2006-03-10 Johnson & Johnson Regimen de dosificacion de farmaco anti-inflamatorio no-esteroideo.
US20040186180A1 (en) * 2003-03-21 2004-09-23 Gelotte Cathy K. Non-steroidal anti-inflammatory drug dosing regimen
EP2190418B1 (en) * 2007-08-15 2013-10-02 Mcneil-PPC, Inc Immediate release and sustained release ibuprofen dosing regimen

Also Published As

Publication number Publication date
EP2190418A1 (en) 2010-06-02
WO2009023030A8 (en) 2010-11-25
EP2190418B1 (en) 2013-10-02
US20120136060A1 (en) 2012-05-31
US8211465B2 (en) 2012-07-03
AU2007357647A1 (en) 2009-02-19
AU2014203508A1 (en) 2014-07-17
JP5345620B2 (ja) 2013-11-20
AU2016203727A1 (en) 2016-06-23
CN101784262A (zh) 2010-07-21
KR101458774B1 (ko) 2014-11-07
KR20100045509A (ko) 2010-05-03
US20090048345A1 (en) 2009-02-19
EP2630955B1 (en) 2021-09-22
PL2190418T3 (pl) 2014-03-31
JP2010536748A (ja) 2010-12-02
CA2696063C (en) 2014-05-06
CA2696063A1 (en) 2009-02-19
AU2018201651B2 (en) 2019-01-03
EP2630955A1 (en) 2013-08-28
ES2438267T3 (es) 2014-01-16
MX2010001789A (es) 2010-03-10
WO2009023030A1 (en) 2009-02-19
AU2018201651A1 (en) 2018-03-29
US8137694B2 (en) 2012-03-20
HK1144071A1 (en) 2011-01-28

Similar Documents

Publication Publication Date Title
BRPI0721969A2 (pt) regime de dosagem de ibuprofeno de liberação imediata e de liberação sustentada
BRPI0817927A2 (pt) Comprimidos orodispersiveis
CY2015013I1 (el) Αντι-μολυσματικες πυραμιδινες και χρησεις αυτων
DE602007011194D1 (de) Fahrrad-Schnellspanner
BRPI0910835A2 (pt) conjunto com pílulas hemostáticas e radiograficamente detectáveis
DK2086504T3 (da) Diclofenac-gel
DK2281006T3 (da) Tværbindingsmidler og anvendelser deraf
BRPI0920521A2 (pt) combinação farmacêutica
DK2274030T4 (da) Lægemiddelafgivelsesanordning
DK2200752T3 (da) Doseringsindretning
BRPI0819846A2 (pt) Material copolimérico anfifílico
BRPI0913377A2 (pt) regime de dosagem
IL204528A (en) Pharmaceutical dosage forms for immediate sustained release of metadoxin
ITMI20060591A1 (it) Innesto rapido
DK2272763T3 (da) Blisterpakning-dispensermaskine
DE602008000272D1 (de) Belastungsvorrichtung
BRPI0922423A2 (pt) dispositivo de liberação de fármaco
BRPI0913913A2 (pt) regime de dosagem para nitrocatecóis
DE602007010950D1 (de) Dosierpumpe
DK2342060T3 (da) Doseringsindretning
BRPI0923891A2 (pt) dispositivo de dosagem
BRPI0910187A2 (pt) película e artigo
BRPI0907011A2 (pt) Formulação de liberação sistentada compreendendo octreotida e três polímeros lineares de polilactpideo de coglicolídeo
DE602007004056D1 (de) Produkttransportvorrichtung
FI20065201A (fi) Poikkisuuntainen venytyslaite

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements